Literature DB >> 182137

Stimulation of prolactin synthesis and of adenosine 3':5'-cyclic phosphate formation by prostaglandins and thyroliberin in cultured rat pituitary cells.

K M Gautvik, M Kriz.   

Abstract

1. The effects of prostaglandins E2 and F2alpha on prolactin synthesis were examined in a clonal strain of rat pituitary tumour cells, and compared with those of thyroliberin. 2. The prostaglandins and thyroliberin gave a dose-related and time-dependent stimulation of prolactin synthesis. The maximal effects (about twofold increases) were observed after 54h of treatment with 25nM-prostaglandin E2 and 2.5nM-prostaglandin F2alpha. A similar stimulation of prolactin synthesis was observed after 250nM-thyroliberin. The combined treatment with prostaglandins and thyroliberin did not increase prolactin synthesis over and above that obtained with each compound alone. 3. After removal of prostaglandins E2 and F2alpha there was a complete reversal of prolactin synthesis to pre-stimulation values 18h later (t1/2less than or equal to 9h). The rapid reversible effect of prostaglandins was in contrast with that of thyroliberin, where prolactin synthesis returned to control values with a t1/2 of about 42 h. 4. Prostaglandin E2 (5mum) and thyroliberin (5mum) increased cellular concentrations of cyclic AMP eight- and four-fold respectively. Maximal effects were observed after 2-5min of incubation. The increases in cyclic AMP were biphasic; normal values were obtained 60 min after the start of incubation with prostaglandin E2 or thyroliberin. 5. The dose/response curve showed that prostaglandin E2 caused maximal increase of cyclic AMP at 50nM. Concentrations of prostagland in E2 that caused half-maximal stimulation of cyclic AMP accumulation and of prolactin synthesis were 4 and 5nM respectively. 6. Combined treatment with prostaglandin E2 and thyroliberin in concentrations that separately caused maximal cyclic AMP increases did not result in a further increase in this cyclic nucleotide. 7. These results are consistent with a role of cyclic AMP in mediating the effects or prostaglandins and thyroliberin on prolactin synthesis. However, if cyclic AMP is involved as a common intracellular mediator of prolactin synthesis, it cannot alone explain all the effects of prostaglandins and thyroliberin in this cell system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182137      PMCID: PMC1163722          DOI: 10.1042/bj1560111

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  An improved nutrient solution for diploid Chinese hamster and human cell lines.

Authors:  R G HAM
Journal:  Exp Cell Res       Date:  1963-02       Impact factor: 3.905

2.  The last conversation with Dr. Earl W. Sutherland, Jr: the feedback regulation of cyclic nucleotides.

Authors:  R J Ho; T Russell; T Asakawa
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Effect of synthetic gonadotrophin-releasing hormone (Gn-RH) on ovulation blockade by aspirin and indomethacin.

Authors:  H R Behrman; G P Orczyk; R O Greep
Journal:  Prostaglandins       Date:  1972-04

5.  Stimulatory effects of prostaglandin e-1 on rat anterior pituitary cyclic AMP and luteinizing hormone release.

Authors:  A Ratner; M C Wilson; L Srivastava; G T Peake
Journal:  Prostaglandins       Date:  1974-01-25

6.  Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture.

Authors:  P M Hinkle; A H Tashjian
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

7.  Effect of prostaglandin F2 alpha on the secretion of human prolactin.

Authors:  D K Yue; I D Smith; J R Turtle; R P Shearman
Journal:  Prostaglandins       Date:  1974-12-10

8.  Effects of thyrotropin-releasing hormone and hydrocortisone on synthesis and degradation of prolactin in a rat pituitary cell strain.

Authors:  P S Dannies; A R Tashjian
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

9.  Release of pituitary growth hormone by prostaglandins and dibutyryl adenosine cyclic 3':5'-monophosphate in the absence of protein synthesis.

Authors:  R M MacLeod; J E Lehmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

10.  Stimulation of anterior pituitary adenyl cyclase activity and adenosine 3':5'-cyclic phosphate by hypothalamic extract and prostaglandin E1.

Authors:  U Zor; T Kaneko; H P Schneider; S M McCann; I P Lowe; G Bloom; B Borland; J B Field
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

View more
  4 in total

1.  Basal and thyroliberin-stimulated prolactin synthesis in single-cell cultures and in populations of rat pituitary cells.

Authors:  K M Gautvik; S Fossum
Journal:  Biochem J       Date:  1976-07-15       Impact factor: 3.857

2.  Morphine and endorphins modulate dopamine turnover in rat median eminence.

Authors:  S N Deyo; R M Swift; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

3.  Effect of thyroliberin on the concentration of adenosine 3':5'-phosphate and on the activity of adenosine 3':5'-phosphate-dependent protein kinase in prolactin-producing cells in culture.

Authors:  K M Gautvik; E Walaas; O Walaas
Journal:  Biochem J       Date:  1977-02-15       Impact factor: 3.857

Review 4.  Histidyl-proline diketopiperazine: its biological role as a regulatory peptide.

Authors:  A Peterkofsky; F Battaini; Y Koch; Y Takahara; P Dannies
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.